Thanks, Reed, and good afternoon, everyone. Thank you for joining us today. We are pleased with our fourth quarter results, including continued growth and improving margins. Revenues increased approximately 13% year-over-year to $55.1 million, driven largely by our MindBody GLP-1 System. Profitability also remained strong, and we delivered 40 basis points of gross margin expansion versus the prior year period. Adjusted EBITDA of $4.8 million was flat versus last year's fourth quarter. While revenues in the Americas region were up a solid 14%, another exciting development was our international business returning to growth for the first time in 12 quarters. For the quarter, revenues in our Asia-Pacific/Europe regions increased by 8%. The rollout of MindBody to Japan, Australia, Europe, and Thailand beginning mid-March was the key driver for higher international sales, and momentum continues to build.Active account metrics reflected the positive trends we are seeing across our business. In the Americas, total active accounts were up 6% versus last year, with increases in both consultants and customers. In Asia-Pacific and in Europe, total active accounts were down versus last year, but increased 3% on a sequential basis as the MindBody rollout led to growth in customers. Average revenue per consultant was up 4% in the Americas and 14% in Asia-Pacific/Europe, further demonstrating the early success of MindBody internationally. Accentuating the incredible year we have had is yesterday's announcement that we have entered into a definitive agreement to acquire the critical assets of LoveBiome, a pioneer direct selling company with a growing global sales presence and strong product philosophy. This strategic partnership enables both consulting groups the opportunity for accelerated growth by cross-selling products, while LifeVantage realizes operational leverage.Two things primarily attracted us to this incredible company. First, LoveBiome has established itself as a leader in the emerging microbiome health sector, focusing on the critical connection between gut health and overall wellness. The company's innovative P84 product, which launched earlier this year, takes the guesswork out of gut health by regulating, repairing, and restoring the gut and microbiome through activation, recognizing that comprehensive gut health is fundamental to health across multiple body systems. The global gut health supplement market is projected to grow from $14.4 billion in 2025 to $32.4 billion by 2035, registering a robust CAGR of 8.4%, making it an attractive category for LifeVantage. P84 also aligns perfectly with our differentiation of activating optimal health processes throughout the body.We feel strongly that LoveBiome's expertise in microbiome science complements LifeVantage's existing portfolio of scientifically validated activators, including our flagship Protandim Nrf2 Synergizer, customer-favorite TrueScience Liquid Collagen, and our newest innovation, the MindBody GLP-1 System. Second, both LoveBiome and LifeVantage believe strongly in the direct sales industry and the empowerment it provides to consultants around the world. The partnership we are entering into accelerates the call to global entrepreneurs to love life with the very best compensation plan, products, and community, while also accelerating the ability for both companies to scale their growth meaningfully and sustainably. By empowering LoveBiome and LifeVantage consultants through our industry-leading Evolve Compensation Plan, with compelling products that address a number of health concerns, we're able to activate wellness, both financially and physically, to a broader base of consumers.I commend LoveBiome's Founder and CEO, Kelly Olson, and his team for continuously championing the direct sales industry while innovating in a growing wellness category. The timing of this strategic acquisition is also a testament to the transformational work the entire LifeVantage team has been delivering the past three years. The success of LifeVantage's LV360 initiatives, which were previously discussed, laid the foundation that now allows for investments into the core business. It's truly an industry-first partnership that scales our path to growth this fiscal year and beyond. Under the terms of the definitive agreement, all critical operating assets essential to the success of LoveBiome members transitioning to LifeVantage consultants, as well as the assets surrounding the microbiome health business, will transfer to LifeVantage.The transaction structure includes the retention of key LoveBiome personnel with Founder and CEO Kelly Olson and other team members joining LifeVantage to ensure continuity of operations and leverage their expertise in the direct selling channel. We are expected to close the transaction by mid-October upon satisfactory and customary closing conditions and regulatory requirements, and plan to be fully integrated by the end of fiscal Q2 2026. Following this strategic transaction, we anticipate our US Momentum Academy being held in Dallas on October 23rd to the 25th to be a historic event. This will be the first time the two active communities will come together in person for training, incentive, and product announcements. We will also be announcing the evolution of our Summer in the Fast Lane campaign.If you remember, we kicked off quarterly campaigns at our Activate Virtually event in July to help consultants of every rank build their business by qualifying for new incentives and growing Activation Nation. We are excited to introduce LoveBiome consultants to the drive era using this quarterly incentive push. Nothing replaces the energy and momentum that comes from meeting in person, and we anticipate a sell-out event. Similar events will be held in several countries throughout the world in October to accelerate a seamless integration of the two companies.Not only are we committed to growing our consultant base through the strategic acquisition and our product and compensation differentiation, but we are also committed to delivering the experience modern, fast-paced consumers demand in today's market. I am excited to announce that we have entered into an agreement with Shopify that will further modernize our technology and marketing stack to meet the increasing demand consumers have throughout the entire customer journey. We have partnered with the very best, most reputable, highest converting e-commerce platform on the market to do so. Simply stated, our Shopify partnership enables significant growth potential for both LifeVantage and our consultants. Shopify delivers increased conversions and brand advocacy through seamless channel experiences, deeper personalization and data insights, and greater consumer confidence with things like payment security, checkout reliability, and order tracking.For our internal team, it also means greater efficiency, faster innovation, and quicker scaling of future integrations. This project is just getting underway with the team wrapping up initial discovery sessions and milestones last week, leading to a full project and rollout plan. We will continue to update you as we progress towards go live, but are excited about completing this early stage and what this project and partnership with Shopify means for LifeVantage. In summary, fourth quarter results were strong, and our business continues to have a lot of momentum powered by innovation. We've built a powerful, dynamic ecosystem focused on holistic wellness, along with a proven model that provides multiple avenues for entrepreneurial success. Our team is highly engaged with an ambitious vision for the future, and we are well positioned for continued growth and margin expansion.The successful global rollout of our MindBody System and this announced partnership with LoveBiome, combined with our strengthened operational foundation and improving profitability metrics, gives us confidence in our ability to deliver sustainable long-term value to our stakeholders. Now let me turn the call over to Carl to review our fourth quarter financial results in detail. Carl?
